PRASAD SUYASH
SEC CIK 1679129 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | CMO, Head of R, D | 530.6K | — | $2.02M | 3 | 2021-06-29 | 2022-07-05 |
Most active insiders at TSHA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nagendran Sukumar | Pres, Head of R, D, Dir | — | $5.33M |
| 2 | Nolan Sean P. | CEO, Dir | — | $840.2K |
| 3 | Alam Kamran | CFO | — | $492.5K |
| 4 | Long Alison S | Dir | — | — |
| 5 | Sepp-Lorenzino Laura | Dir | — | — |
| 6 | Stalfort John A III | Dir | — | — |
| 7 | Donenberg Phillip B. | Dir | — | — |
PRASAD SUYASH made no open-market trades at TSHA in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-07-07 | 2022-07-05+ | TSHA | Taysha Gene Therapies, Inc. | PRASAD SUYASH | CMO, Head of R, D | S - Sale | $3.70 | -12.9K | 530.6K | -2% | -$47.6K |
| M | 2022-07-01 | 2022-06-29+ | TSHA | Taysha Gene Therapies, Inc. | PRASAD SUYASH | CMO, Head of R, D | S - Sale | $3.65 | -50.1K | 581.3K | -8% | -$183.1K |
| M | 2021-07-01 | 2021-06-29+ | TSHA | Taysha Gene Therapies, Inc. | PRASAD SUYASH | CMO, Head of R, D | S - Sale | $22.63 | -79.0K | 633.4K | -11% | -$1.79M |
Purchase Sale Sale after option exercise All abbreviations